Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.65
Delayed Data
As of 8:00pm ET
 +0.05 / +3.12%
Today’s Change
1.42
Today|||52-Week Range
4.84
-18.32%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close1.60
Today’s open1.61
Day’s range1.60 - 1.66
Volume135,828
Average volume (3 months)323,154
Market cap$52.7M
Data as of 8:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-133.33%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.31

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc+0.02+0.93%
EIGREiger BioPharmaceuti...-0.85-7.62%
NOVNNovan Inc-0.04-1.26%
NBYNovaBay Pharmaceutic...+0.10+3.08%
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateMay 14, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
President &
Chief Financial Officer
Douglas J. Swirsky
Corporate headquarters
Rockville, Maryland

Forecasts